Cargando…
Advanced Glycation End Products Increase MDM2 Expression via Transcription Factor KLF5
Type 2 diabetes increases the risk for all-site cancers including colon cancer. Diabetic patients present typical pathophysiological features including an increased level of advanced glycation end products (AGEs), which comes from a series of nonenzymatic reactions between sugars and biological macr...
Autores principales: | Wang, Pu, Lu, Yu Cheng, Li, Yuan Fei, Wang, Lan, Lee, Shao Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151196/ https://www.ncbi.nlm.nih.gov/pubmed/30271790 http://dx.doi.org/10.1155/2018/3274084 |
Ejemplares similares
-
Advanced glycation end products increase lipids accumulation in macrophages through upregulation of receptor of advanced glycation end products: increasing uptake, esterification and decreasing efflux of cholesterol
por: Xu, Lei, et al.
Publicado: (2016) -
Advanced Glycation End Products and Psoriasis
por: Maurelli, Martina, et al.
Publicado: (2023) -
Echinacoside-Zinc
Nanomaterial Inhibits Skin Glycation
by Suppressing the Transcriptional Activation of the Receptor for
Advanced Glycation End-Products
por: Han, Jingxia, et al.
Publicado: (2023) -
Dietary Advanced Glycation End Products and Aging
por: Luevano-Contreras, Claudia, et al.
Publicado: (2010) -
Advanced Glycation End Products and Diabetic Complications
por: Singh, Varun Parkash, et al.
Publicado: (2014)